科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

科华智慧（深圳）创新药物研发有限公司海根生物(深圳)有限公司联合开发

中文 EN

主页

产品

天然产物数据库

技术服务

科技资讯

公司介绍

联系方式

中文 EN

植物来源

结构类型

微生物来源

大品种

合成化合物

-合成化合物

CAS No.	英文名/中文名/SMILES	分子式	分子量	含量	价格	二维结构图
1414356-33-4	(R)-3-(2-((4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)pyrrolidin-1-yl)-3-oxopropanenitrile 1414356-33-4	C₂₅H₂₂FN₇O₂	471.5	98%	点击查询
1415329-13-3	[4-[[2-[(2-amino-3-methylbutanoyl)amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[1-[[1-[[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate VAL-CIT-PAB-MMAD	C₆₀H₉₃N₁₁O₁₁S	1176.5	98%	点击查询
1416799-28-4	(S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid AMG-333	C₂₀H₁₂F₅N₃O₄	453.3	98%	点击查询
1417997-93-3	Hdac8-IN-1 MDK-7933	C₂₂H₁₉NO₃	345.4	98%	点击查询
1418274-28-8	Cilofexor Cilofexor	C₂₈H₂₂Cl₃N₃O₅	586.8	98%	点击查询
1421923-86-5	(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide KPT-330, (E)-RN	C₁₇H₁₁F₆N₇O	443.3	98%	点击查询
1429054-28-3	2-(4-(Adamantan-1-yl)phenoxy)-1-(4-methylpiperazin-1-yl)ethanone IDF-11774	C₂₃H₃₂N₂O₂	368.5	98%	点击查询
1429757-68-5	Poziotinib hydrochloride HM 781-36B	C₂₃H₂₂Cl₃FN₄O₃	527.8	98%	点击查询
1430723-35-5	N-[3-(2,4-difluorophenyl)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]cyclopropanesulfonamide ODM-203	C₂₆H₂₁F₂N₅O₂S	505.5	98%	点击查询
1433990-32-9	6,7,8,9-Tetrahydropyrazino[1,2-a]indol-1(2H)-one 6,7,8,9-tetrahydropyrazino[1,2-a]indol-1(2H)-one	C₁₁H₁₂N₂O	188.23	98%	点击查询

(R)-3-(2-((4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)pyrrolidin-1-yl)-3-oxopropanenitrile

C₂₅H₂₂FN₇O₂ 471.5

[4-[[2-[(2-amino-3-methylbutanoyl)amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[1-[[1-[[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate

VAL-CIT-PAB-MMAD

C₆₀H₉₃N₁₁O₁₁S 1176.5

(S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid

C₂₀H₁₂F₅N₃O₄ 453.3

C₂₂H₁₉NO₃ 345.4

C₂₈H₂₂Cl₃N₃O₅ 586.8

(E)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide

KPT-330, (E)-RN

C₁₇H₁₁F₆N₇O 443.3

2-(4-(Adamantan-1-yl)phenoxy)-1-(4-methylpiperazin-1-yl)ethanone

C₂₃H₃₂N₂O₂ 368.5

Poziotinib hydrochloride

C₂₃H₂₂Cl₃FN₄O₃ 527.8

N-[3-(2,4-difluorophenyl)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]cyclopropanesulfonamide

C₂₆H₂₁F₂N₅O₂S 505.5

6,7,8,9-Tetrahydropyrazino[1,2-a]indol-1(2H)-one

6,7,8,9-tetrahydropyrazino[1,2-a]indol-1(2H)-one

C₁₁H₁₂N₂O 188.23

<上一页 1 2 3 4 5 6 7 8 9 10 ... (当前15618页) 16106 下一页>

本公司所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

公司地址:深圳市南山区粤海街道高新区社区粤兴二道1号虚拟大学园重点实验室平台大楼B410

电话:400-856-5689

邮箱:kehuaai@kehuaai.com

科华智慧（深圳）创新药物研发有限公司

备案号：粤ICP备2024241782号